FILE:MDT/MDT-8K-20041206155430.txt.gz
EVENTS:	Results of Operations and Financial Condition	Financial Statements and Exhibits
TEXT:
ITEM: Results of Operations and Financial Condition
ITEM: Financial Statements and Exhibits
 
 
 
 
710 Medtronic Parkway
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
                
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
                
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
                
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
                
 
 
 
Item 2.02.
Results of Operations and Financial Condition
                                         
 
On November 17, 2004, Medtronic, Inc. issued a press release announcing its fiscal
2005 second quarter financial results. The press release contained an incorrect product reference when it stated that: "Medtronic expects to introduce the ADVANTAGE
Supra
bileaflet mechanical aortic heart valve in the spring of 2005." The actual product name is the ADVANTAGE
bileaflet mechanical aortic heart valve.
 
The information in this Current Report shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, and shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended.
 
Item 9.01.
Financial Statements and Exhibits.
                                         
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly  authorized.
 
 


